RT @doctorRBC: Secukinumab effective in AS patients, irrespective of gender AQUILA 52 week study âï¸improvement in BA
Tweet Content
Secukinumab effective in AS patients, irrespective of gender
AQUILA 52 week study
⭐️improvement in BASDAI, PGA, severity of depressive mood in both men and women
⭐️women had overall higher disease burden in global functioning and depressive mood
POS0899
#EULAR2021 @RheumNow
Show on Archive Page
On
Display in Search Results
On
PDQ
Off